Found 20 matching trials
Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer PHASE2 This study enrolled participants with previously-treated advanced or inoper...
Show More Location
Miami Cancer Institute
Learn More & Join Trial
Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors PHASE1 This study is designed to evaluate the safety, tolerability, PKharmacokinet...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer PHASE1 The study was an open-label, parallel-group, fixed-sequence study in male a...
Show More Location
Arensia Exploratory Medicine Llc
Learn More & Join Trial
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies PHASE3 This is an open-label, multicenter, extension study to evaluate the long-te...
Show More Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Learn More & Join Trial
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations PHASE1 This phase I/II trial studies the side effects and how well BGB-290 and tem...
Show More Location
UAB Comprehensive Cancer Center
Learn More & Join Trial
Phase 1a/1b BGB-290 for Advanced Solid Tumors. PHASE1 The study contains Phase 1A and Phase 1B. Phase 1A has Part1 (BID Dose Esca...
Show More Learn More & Join Trial
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors PHASE1 The primary objective of this study was to determine the safety and tolerab...
Show More Learn More & Join Trial
Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy PHASE2 This study is a phase II, multi-centre, open label study in patients with a...
Show More Location
Multiple Locations
Learn More & Join Trial
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer PHASE1 The purpose of this study was to investigate the efficacy and safety of pam...
Show More Location
Affiliated Hospital of Jiangnan University
Learn More & Join Trial
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma PHASE1 The primary objective of this study is to evaluate the safety, efficacy and...
Show More Location
Center For Neurosciences
Learn More & Join Trial